Works matching IS 10781552 AND DT 2024 AND VI 30 AND IP 3
Results: 21
Selinexor for the treatment of patients with relapsed or refractory multiple myeloma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 3, p. 535, doi. 10.1177/10781552241235902
- By:
- Publication type:
- Article
Cyclin-dependent kinase 4/6 inhibitors in the treatment of advanced or metastatic breast cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 3, p. 547, doi. 10.1177/10781552241232701
- By:
- Publication type:
- Article
Drug-related problems in cancer patients: A systematic review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 3, p. 562, doi. 10.1177/10781552241229662
- By:
- Publication type:
- Article
Rechallenges without desensitization following platinum-based chemotherapy reactions.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 3, p. 572, doi. 10.1177/10781552241229024
- By:
- Publication type:
- Article
Chemotherapeutic metabolism presenting as a recalcitrant case of hand–foot syndrome and mucositis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 3, p. 584, doi. 10.1177/10781552241226595
- By:
- Publication type:
- Article
Hyperammonemic encephalopathy after tyrosine kinase inhibitors: A literature review and a case example.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 3, p. 576, doi. 10.1177/10781552231225188
- By:
- Publication type:
- Article
Nivolumab treatment in a patient with BRAF mutant advanced melanoma and liver failure with encephalopathy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 3, p. 589, doi. 10.1177/10781552231221230
- By:
- Publication type:
- Article
Management of Nelarabine induced neurotoxicity in a child with T-cell acute lymphoblastic lymphoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 3, p. 594, doi. 10.1177/10781552231221219
- By:
- Publication type:
- Article
Use of venetoclax in t(11;14) positive relapsed/refractory multiple myeloma: A systematic review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 3, p. 552, doi. 10.1177/10781552231218999
- By:
- Publication type:
- Article
Successful management of camrelizumab-induced immune-checkpoint-inhibitors-related myocarditis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 3, p. 597, doi. 10.1177/10781552231216104
- By:
- Publication type:
- Article
Hypercalcemia associated with interaction between all trans retinoic acid and fluconazole in an acute promyelocytic leukemia and acquired hypoparathyroidism case.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 3, p. 605, doi. 10.1177/10781552231216050
- By:
- Publication type:
- Article
Patient and caregiver experience with telepharmacy in cancer care to support beginning systemic therapy: A qualitative study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 3, p. 442, doi. 10.1177/10781552231181911
- By:
- Publication type:
- Article
Safety and efficacy of vitamin B in cancer treatments: A systematic review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 3, p. 451, doi. 10.1177/10781552231178686
- By:
- Publication type:
- Article
Quantifying chemotherapy wastage in an ambulatory cancer centre in Singapore.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 3, p. 464, doi. 10.1177/10781552231178678
- By:
- Publication type:
- Article
Determining acceptance and perceptions of chemotherapy dose banding in an ambulatory cancer centre.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 3, p. 474, doi. 10.1177/10781552231178675
- By:
- Publication type:
- Article
Extravasation of monoclonal antibodies commonly used in oncology: Classification, management and the role of the pharmacist.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 3, p. 488, doi. 10.1177/10781552231178674
- By:
- Publication type:
- Article
Drug-related problems among esophageal, gastric and colorectal cancer patients at the National and referral hospital in Kenya.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 3, p. 493, doi. 10.1177/10781552231178297
- By:
- Publication type:
- Article
Retrospective study on the efficacy and tolerability of dose modification of PD-1 and PD-L1 inhibitors in hospital-system community outpatient cancer clinics.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 3, p. 507, doi. 10.1177/10781552231177209
- By:
- Publication type:
- Article
Comparison of differing dose levels of methotrexate for patients with primary central nervous system lymphoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 3, p. 513, doi. 10.1177/10781552231176754
- By:
- Publication type:
- Article
Redispensing of expensive oral anticancer medicines: A practical application.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 3, p. 519, doi. 10.1177/10781552231176199
- By:
- Publication type:
- Article
Isavuconazonium or posaconazole for antifungal prophylaxis in patients with acute myeloid leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 3, p. 527, doi. 10.1177/10781552231175825
- By:
- Publication type:
- Article